← FDA DRUG APPROVALS

FDA ANDA · ANDA084767

DIMENHYDRINATE

Sponsor: BAXTER HLTHCARE

APPLICATION
ANDA084767
TYPE
ANDA
ORIGINAL APPROVAL
1976-09-13
LATEST ACTION
1992-02-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DIMENHYDRINATEDiscontinued
DIMENHYDRINATE 50MG/ML · INJECTABLE · INJECTION

Approval history

1992-02-27Manufacturing (CMC) · Supplement 12AP
1987-11-06Manufacturing (CMC) · Supplement 11AP
1982-07-28Manufacturing (CMC) · Supplement 9AP
1976-09-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →